The finding suggests that measuring levels of antibodies in the blood could be used to assess a person's heart attack risk, according to researchers from Imperial College London and University College London in the UK.
The study shows a link between the amount of IgG antibodies in a person's blood and their likelihood of being protected against an adverse cardiac event, such as a heart attack, researchers said.
Measuring IgG is simple and cheap, so scientists suggest that this finding could, in the future, make it easier for clinicians to more accurately determine a person's risk of having a heart attack.
"Linking a stronger, more robust immune system to protection from heart attacks is a really exciting finding," said Ramzi Khamis from Imperial College.
More From This Section
"As well as improving the way we tell who is at the highest risk of a heart attack so that we can give them appropriate treatments, we now have a new avenue to follow in future work," said Khamis.
Researchers studied patients who suffered a heart attack or stroke from the Anglo Scandinavian Cardiac Outcomes Trial (ASCOT) with their matched controls. People enrolled on the ASCOT trial had high blood pressure and were at high risk of a cardiovascular event.
Researchers measured levels of total IgG and IgM antibodies, as well as levels of antibodies that are particular to an oxidised form of 'bad' cholesterol, oxLDL, which is known to promote atherosclerosis - the build-up of fatty material in the artery walls that can lead to heart attacks.
Total IgG levels showed the strongest association with reduced heart attack risk, independent of other risk factors such as cholesterol levels or blood pressure, researchers said.
The findings were published in the journal EbioMedicine.